Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.35 - $0.53 $2,086 - $3,158
5,960 Added 98.77%
11,994 $6,000
Q3 2023

Nov 14, 2023

BUY
$0.38 - $0.58 $2,292 - $3,499
6,034 New
6,034 $2,000
Q1 2023

May 15, 2023

SELL
$0.79 - $1.91 $119,018 - $287,752
-150,656 Reduced 55.84%
119,153 $97,000
Q4 2022

Feb 14, 2023

SELL
$1.41 - $2.5 $222,994 - $395,380
-158,152 Reduced 36.95%
269,809 $420,000
Q3 2022

Nov 14, 2022

BUY
$1.66 - $2.79 $710,415 - $1.19 Million
427,961 New
427,961 $738,000
Q1 2022

May 16, 2022

SELL
$2.97 - $5.2 $189,144 - $331,162
-63,685 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $305,313 - $456,440
61,185 Added 2447.4%
63,685 $318,000
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $17,900 - $24,225
2,500 New
2,500 $18,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $182,638 - $294,039
-29,316 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $186,631 - $359,280
21,184 Added 260.5%
29,316 $272,000
Q4 2020

Feb 16, 2021

SELL
$8.5 - $12.85 $301,614 - $455,969
-35,484 Reduced 81.36%
8,132 $72,000
Q3 2020

Nov 16, 2020

BUY
$9.57 - $27.05 $417,405 - $1.18 Million
43,616 New
43,616 $506,000
Q1 2020

May 15, 2020

SELL
$2.98 - $14.09 $37,247 - $176,110
-12,499 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.97 - $3.72 $24,623 - $46,496
12,499 New
12,499 $41,000
Q3 2019

Nov 14, 2019

SELL
$2.05 - $3.02 $67,244 - $99,062
-32,802 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.29 - $4.1 $43,839 - $78,490
19,144 Added 140.17%
32,802 $96,000
Q1 2019

May 15, 2019

SELL
$3.34 - $5.1 $17,645 - $26,943
-5,283 Reduced 27.89%
13,658 $51,000
Q4 2018

Feb 14, 2019

BUY
$3.89 - $6.11 $73,680 - $115,729
18,941 New
18,941 $76,000
Q2 2018

Aug 14, 2018

SELL
$3.88 - $5.16 $78,903 - $104,933
-20,336 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.05 - $5.69 $82,360 - $115,711
20,336 New
20,336 $96,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.